NYSE:CIA Citizens Stock Forecast, Price & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Citizens, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $5.25 -0.01 (-0.19 %) (As of 09/25/2020 12:00 AM ET) Add Compare Share Today's Range$5.20Now: $5.25▼$5.3650-Day Range$5.18MA: $5.87▼$6.1352-Week Range$3.55Now: $5.25▼$7.28Volume46,361 shsAverage Volume88,295 shsMarket Capitalization$280.84 millionP/E Ratio87.50Dividend YieldN/ABeta0.33 ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial Media Citizens, Inc., through its subsidiaries, provides life insurance products in the United States and internationally. It operates in two segments, Life Insurance and Home Service Insurance. The Life Insurance segment issues ordinary whole life insurance and endowment policies in the United States dollar-denominated amounts to international residents in approximately 20 countries through 1,110 independent marketing consultants, as well as through approximately 50 independent marketing firms and consultants throughout the United States. It also provides health insurance policies. The Home Service Insurance segment offers pre-need and final expense ordinary life insurance, and annuities to middle and lower income individuals primarily in Louisiana, Mississippi, and Arkansas. It provides its products and services through funeral homes and independent agents, as well as through a home service marketing distribution system. The company was founded in 1969 and is headquartered in Austin, Texas.Read More Beat the Market (BTM) Rank™ 1.5 Analyst's Opinion Consensus RatingCitizens has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $3.00, Citizens has a forecasted downside of 42.9% from its current price of $5.25.Amount of Analyst CoverageCitizens has received no research coverage in the past 90 days. Previous Next 2.5 Community Rank Outperform VotesCitizens has received 207 “outperform” votes. (Add your “outperform” vote.)Underperform VotesCitizens has received 211 “underperform” votes. (Add your “underperform” vote.)Community SentimentCitizens has received 50.48% “underperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about Citizens and other stocks. Vote “Outperform” if you believe CIA will outperform the S&P 500 over the long term. Vote “Underperform” if you believe CIA will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldCitizens does not currently pay a dividend.Dividend GrowthCitizens does not have a long track record of dividend growth. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Citizens insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 0.49% of the stock of Citizens is held by insiders.Percentage Held by InstitutionsOnly 22.98% of the stock of Citizens is held by institutions. Previous Next 0.0 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of Citizens is 87.50, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 18.34.Price to Earnings Ratio vs. SectorThe P/E ratio of Citizens is 87.50, which means that it is trading at a more expensive P/E ratio than the Finance sector average P/E ratio of about 17.26.Price to Book Value per Share RatioCitizens has a P/B Ratio of 1.08. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next Analyst Opinion: 1.5Community Rank: 2.5Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -Overall Beat the Market Rank™0.80 out of 5 stars Industry, Sector and Symbol Stock Exchange NYSE Industry Life insurance Sub-IndustryLife & Health Insurance SectorFinance Current SymbolNYSE:CIA Previous Symbol CUSIP17474010 CIK24090 Webwww.citizensinc.com Phone512-837-7100Debt Debt-to-Equity RatioN/A Current Ratio0.06 Quick Ratio0.06Price-To-Earnings Trailing P/E Ratio87.50 Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales$250.54 million Price / Sales1.12 Cash Flow$0.26 per share Price / Cash Flow20.13 Book Value$4.87 per share Price / Book1.08Profitability EPS (Most Recent Fiscal Year)N/A Net Income$-1,370,000.00 Net Margins0.97% Return on Equity0.93% Return on Assets0.14%Miscellaneous EmployeesN/A Outstanding Shares53,493,000Market Cap$280.84 million Next Earnings Date11/4/2020 (Estimated) OptionableOptionable $5.25 -0.01 (-0.19 %) (As of 09/25/2020 12:00 AM ET) 30 days | 90 days | 365 days | Advanced Chart Receive CIA News and Ratings via Email Sign-up to receive the latest news and ratings for CIA and its competitors with MarketBeat's FREE daily newsletter. Citizens (NYSE:CIA) Frequently Asked Questions How has Citizens' stock been impacted by COVID-19? Citizens' stock was trading at $4.57 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, CIA stock has increased by 14.9% and is now trading at $5.25. View which stocks have been most impacted by COVID-19. Do Wall Street analysts recommend investors buy shares of Citizens? 1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Citizens in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Citizens. When is Citizens' next earnings date? Citizens is scheduled to release its next quarterly earnings announcement on Wednesday, November 4th 2020. View our earnings forecast for Citizens. How were Citizens' earnings last quarter? Citizens, Inc. (NYSE:CIA) announced its quarterly earnings results on Wednesday, August, 5th. The insurance provider reported ($0.02) earnings per share (EPS) for the quarter. The insurance provider earned $56.89 million during the quarter. Citizens had a return on equity of 0.93% and a net margin of 0.97%. View Citizens' earnings history. What price target have analysts set for CIA? 1 equities research analysts have issued 12 month price targets for Citizens' stock. Their forecasts range from $3.00 to $3.00. On average, they expect Citizens' share price to reach $3.00 in the next year. This suggests that the stock has a possible downside of 42.9%. View analysts' price targets for Citizens. Who are some of Citizens' key competitors? Some companies that are related to Citizens include Metlife (MET), AFLAC (AFL), Prudential Financial (PRU), Principal Financial Group (PFG), Lincoln National (LNC), Primerica (PRI), Unum Group (UNM), CNO Financial Group (CNO), American Equity Investment Life (AEL), FBL Financial Group (FFG), National Western Life Group (NWLI), Independence (IHC), Health Insurance Innovations (HIIQ) and Kansas City Life Insurance (KCLI). View all competitors. What other stocks do shareholders of Citizens own? Based on aggregate information from My MarketBeat watchlists, some companies that other Citizens investors own include Corcept Therapeutics (CORT), Fate Therapeutics (FATE), Huntington Bancshares (HBAN), KeyCorp (KEY), People's United Financial (PBCT), Primo Water (PRMW), AT&T (T), AES (AES), AK Steel (AKS) and Advanced Micro Devices (AMD). Who are Citizens' key executives? Citizens' management team includes the following people: Mr. Geoffrey Martin Kolander, Pres & CEO (Age 43)Mr. Jeffery Paul Conklin, Interim CFO, Interim Chief Investment Officer, Chief Accounting Officer, VP & Treasurer (Age 49)Ms. Kay Elizabeth Osbourn, Head of Financial Reporting (Age 52)Mr. James A. Eliasberg, VP, Chief Legal Officer & Corp. Sec. (Age 61)Mr. Robert McHardy Mauldin III, VP & Chief Marketing Officer (Age 58) What is Citizens' stock symbol? Citizens trades on the New York Stock Exchange (NYSE) under the ticker symbol "CIA." Who are Citizens' major shareholders? Citizens' stock is owned by a variety of retail and institutional investors. Top institutional investors include Charles Schwab Investment Management Inc. (0.62%), Bank of New York Mellon Corp (0.40%), Nuveen Asset Management LLC (0.36%), Bridgeway Capital Management Inc. (0.32%), Swiss National Bank (0.21%) and Goldman Sachs Group Inc. (0.08%). Company insiders that own Citizens stock include Robert B Sloan Jr and Wouters Wayne. View institutional ownership trends for Citizens. Which major investors are selling Citizens stock? CIA stock was sold by a variety of institutional investors in the last quarter, including UBS Group AG, Goldman Sachs Group Inc., and Nuveen Asset Management LLC. View insider buying and selling activity for Citizens. Which major investors are buying Citizens stock? CIA stock was purchased by a variety of institutional investors in the last quarter, including Bridgeway Capital Management Inc., Swiss National Bank, Bank of America Corp DE, SG Americas Securities LLC, Charles Schwab Investment Management Inc., Bank of New York Mellon Corp, and PDT Partners LLC. View insider buying and selling activity for Citizens. How do I buy shares of Citizens? Shares of CIA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. What is Citizens' stock price today? One share of CIA stock can currently be purchased for approximately $5.25. How big of a company is Citizens? Citizens has a market capitalization of $280.84 million and generates $250.54 million in revenue each year. What is Citizens' official website? The official website for Citizens is www.citizensinc.com. How can I contact Citizens? Citizens' mailing address is 14231 TANDEM BOLIVERD 2ND FLOOR, AUSTIN TX, 78714. The insurance provider can be reached via phone at 512-837-7100. This page was last updated on 9/27/2020 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings
